HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy

The incidence of narcolepsy type 1 (NT1) increased in Sweden following the 2009–2010 mass-vaccination with the influenza Pandemrix-vaccine. NT1 has been associated with Human leukocyte antigen (HLA) DQB1*06:02 but full high-resolution HLA-typing of all loci in vaccine-induced NT1 remains to be done. Therefore, here we performed HLA typing by sequencing HLA-DRB3, DRB4, DRB5, DRB1, DQA1, DQB1, DPA1 and DPB1 in 31 vaccine-associated NT1 patients and 66 of their first-degree relatives (FDR), and compared these data to 636 Swedish general population controls (GP). Previously reported disease-related alleles in the HLA-DRB5*01:01:01-DRB1*15:01:01-DQA1*01:02:01-DQB1*06:02:01 extended haplotype were increased in NT1 patients (34/62 haplotypes, 54.8%) compared to GP (194/1272 haplotypes, 15.3%, p = 6.17E-16). Indeed, this extended haplotype was found in 30/31 patients (96.8%) and 178/636 GP (28.0%). In total, 15 alleles, four extended haplotypes, and six genotypes were found to be increased or decreased in frequency among NT1 patients compared to GP. Among subjects with the HLA-DRB5*01:01:01-DRB1*15:01:01-DQA1*01:02-DQB1*06:02 haplotype, a second DRB4*01:03:01-DRB1*04:01:01-DQA1*03:02//*03:03:01-DQB1*03:01:01 haplotype (p = 2.02E-2), but not homozygosity for DRB1*15:01:01-DQB1*06:02:01 (p = 7.49E-1) conferred association to NT1. Alleles with increased frequency in DQA1*01:02:01 (p = 1.07E-2) and DQA1*03:02//*03:03:01 (p = 3.26E-2), as well as with decreased frequency in DRB3*01:01:02 (p = 8.09E-3), DRB1*03:01:01 (p = 1.40E-2), and DQB1*02:01:01 (p = 1.40E-2) were found among patients compared to their FDR. High-resolution HLA sequencing in Pandemrix-associated NT1 confirmed the strong association with the DQB1*06:02:01-containing haplotype but also revealed an increased association to the not previously reported extended HLA-DRB4*01:03:01-DRB1*04:01:01-DQA1*03:02//*03:03:01-DQB1*03:01:01 haplotype. High-resolution HLA typing should prove useful in dissecting the immunological mechanisms of vaccination-associated NT1.

[1]  Sebastiaan Overeem,et al.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains , 2000, Nature Medicine.

[2]  E. Mignot,et al.  DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans. , 2007, Human immunology.

[3]  M. Partinen,et al.  Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis. , 2017, Sleep medicine reviews.

[4]  B. Becher,et al.  T cells in patients with narcolepsy target self-antigens of hypocretin neurons , 2018, Nature.

[5]  Anajane G. Smith,et al.  An integrated genotyping approach for HLA and other complex genetic systems. , 2015, Human immunology.

[6]  Anajane G. Smith,et al.  Next generation sequencing to determine HLA class II genotypes in a cohort of hematopoietic cell transplant patients and donors. , 2014, Human immunology.

[7]  E. Mignot,et al.  Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic , 2013, Annals of neurology.

[8]  N. Laird,et al.  Estimation and Tests of Haplotype-Environment Interaction when Linkage Phase Is Ambiguous , 2003, Human Heredity.

[9]  E. Bonifacio,et al.  Type 1 diabetes mellitus , 2017, Nature Reviews Disease Primers.

[10]  J. Oxford,et al.  Correlation between Human Leukocyte Antigen Class II Alleles and HAI Titers Detected Post-Influenza Vaccination , 2013, PloS one.

[11]  Å. Lernmark,et al.  Early prediction of autoimmune (type 1) diabetes , 2017, Diabetologia.

[12]  E. Mignot,et al.  Genome Wide Analysis of Narcolepsy in China Implicates Novel Immune Loci and Reveals Changes in Association Prior to Versus After the 2009 H1N1 Influenza Pandemic , 2013, PLoS genetics.

[13]  M. Carrington,et al.  Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects , 2013, PLoS genetics.

[14]  M. Partinen,et al.  Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland , 2012, PloS one.

[15]  Michael Aldrich,et al.  Reduced Number of Hypocretin Neurons in Human Narcolepsy , 2000, Neuron.

[16]  T. Olsson,et al.  The immunogenetics of narcolepsy associated with A(H1N1)pdm09 vaccination (Pandemrix) supports a potent gene–environment interaction , 2017, Genes and Immunity.

[17]  E. Mignot,et al.  Genetic and familial aspects of narcolepsy , 1998, Neurology.

[18]  F. Granath,et al.  Risks of neurological and immune‐related diseases, including narcolepsy, after vaccination with Pandemrix: a population‐ and registry‐based cohort study with over 2 years of follow‐up , 2014, Journal of internal medicine.

[19]  A. Desautels,et al.  HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. , 2015, American journal of human genetics.

[20]  Sebastiaan Overeem,et al.  Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy , 2010, Nature Genetics.

[21]  H. Ullum,et al.  CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens , 2019, Nature Communications.

[22]  Evelyn MacLagan,et al.  Narcolepsy , 1929, Edinburgh medical journal.

[23]  C. Wadelius,et al.  Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival , 2019, EBioMedicine.

[24]  L. Zhao,et al.  Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes , 2016, Diabetes.

[25]  E. Mignot,et al.  HLA-DQ association and allele competition in Chinese narcolepsy. , 2012, Tissue antigens.

[26]  S. Himanen,et al.  AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland , 2012, PloS one.

[27]  E. Mignot,et al.  Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy , 2018, Proceedings of the National Academy of Sciences.

[28]  E. Mignot,et al.  Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china , 2011, Annals of neurology.

[29]  J. Touchon,et al.  A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1 , 2004, Neurology.

[30]  Å. Lernmark,et al.  Autoantibodies in Pandemrix®-induced narcolepsy: Nine candidate autoantigens fail the conformational autoantibody test , 2019, Autoimmunity.

[31]  H. Payami,et al.  Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. , 1989, American journal of human genetics.

[32]  G. Plazzi,et al.  Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination , 2014, The Lancet Neurology.

[33]  Z. Kutalik,et al.  DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. , 2014, Sleep.

[34]  E. Mignot,et al.  HLA-DQ allele competition in narcolepsy: a comment on Tafti et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. , 2015, Sleep.

[35]  N. Darín,et al.  Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination , 2013, Neurology.

[36]  D. Schaid,et al.  Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.